| Model evaluation of continuous data pharmacometric models: metrics and graphics THT Nguyen, MS Mouksassi, N Holford, N Al‐Huniti, I Freedman, ... CPT: pharmacometrics & systems pharmacology 6 (2), 87-109, 2017 | 298 | 2017 |
| The Ratio of H 2 Column Density to 12CO Intensity in the Vicinity of the Galactic Center TJ Sodroski, N Odegard, E Dwek, MG Hauser, BA Franz, I Freedman, ... Astrophysical Journal v. 452, p. 262 452, 262, 1995 | 158 | 1995 |
| Immuno-PET imaging to assess target engagement: Experience from 89Zr-anti-HER3 mAb (GSK2849330) in patients with solid tumors CW Menke-Van Der Houven, A McGeoch, M Bergstrom, I McSherry, ... Journal of Nuclear Medicine 60 (7), 902-909, 2019 | 48 | 2019 |
| Model evaluation group of the international society of pharmacometrics (ISoP) best practice committee TH Nguyen, MS Mouksassi, N Holford, N Al-Huniti, I Freedman, ... Model evaluation of continuous data pharmacometric models: metrics and …, 2017 | 33 | 2017 |
| Estimating parameters of nonlinear dynamic systems in pharmacology using chaos synchronization and grid search N Pillai, SL Schwartz, T Ho, A Dokoumetzidis, R Bies, I Freedman Journal of pharmacokinetics and pharmacodynamics 46, 193-210, 2019 | 23 | 2019 |
| Systems aspects of COBE science data compression I Freedman, E Boggess, E Seiler NASA. Goddard Space Flight Center, The 1993 Space and Earth Science Data …, 1993 | 12 | 1993 |
| Model evaluation of continuous data pharmacometric models: metrics and graphics. CPT Pharmacometrics Syst Pharmacol 6: 87–109 THT Nguyen, MS Mouksassi, N Holford, N Al-Huniti, I Freedman, ... | 9 | 2017 |
| Chaos synchronization and Nelder-Mead search for parameter estimation in nonlinear pharmacological systems: Estimating tumor antigenicity in a model of immunotherapy N Pillai, M Craig, A Dokoumetzidis, SL Schwartz, R Bies, I Freedman Progress in biophysics and molecular biology 139, 23-30, 2018 | 8 | 2018 |
| Model Evaluation Group of the International Society of PharmacometricsISoP Best Practice Committee, 2016 THT Nguyen, MS Mouksassi, N Holford, N Al-Huniti, I Freedman, ... Model evaluation of continuous data pharmacometric models: metrics and …, 0 | 6 | |
| Novel uses FJ Derosier, I Freedman, O Graff, RA Grove US Patent App. 13/978,723, 2013 | 5 | 2013 |
| Elucidating Exposure-Response (Safety and Efficacy) of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Containing Antibody Drug Conjugate, for Recommended … OA O'Connor, BS Kahl, M Hamadani, P Caimi, E Reid, J Feingold, ... Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 2543 …, 2017 | 4 | 2017 |
| System for forecasting outcomes of clinical trials I Freedman US Patent App. 12/176,391, 2011 | 4 | 2011 |
| Model evaluation of continuous data pharmacometric models: metrics and graphics. CPT Pharmacometrics Syst Pharmacol. 2017; 6 (2): 87–109 TH Nguyen, MS Mouksassi, N Holford, N Al-Huniti, I Freedman, ... | 4 | |
| Video compression. JB Freedman | 3 | 1992 |
| ImmunoPET imaging to assess target engagement: Experience from Zr-89-anti-HER3 mAb (GSK2849330) in patients with solid tumors A Mcgeoch, M Bergstrom, I McSherry, D Smith, M Cleveland, O Hoekstra, ... European journal of nuclear medicine and molecular imaging 44, S314-S315, 2017 | 2 | 2017 |
| The Relationship Between Peripheral B-Cell Levels and MRI Disease Activity in Relapsing Remitting Multiple Sclerosis (RRMS) D Austin, I Freedman, R Grove, J Tolson, S Vanmeter Neurology 83 (2), E36-E36, 2014 | 1 | 2014 |
| Pharmaco-Imaging in Translational Science and Research I Freedman Pharmaco-Imaging in Drug and Biologics Development: Fundamentals and …, 2013 | 1 | 2013 |
| COBE Astronomical Databases I Freedman, AC Raugh, ES Cheng Astronomical Data Analysis Software and Systems I 25, 64, 1992 | 1 | 1992 |
| COBE ground segment attitude determination VK Kumar, I Freedman, EL Wright, FS Patt NASA. Goddard Space Flight Center, Flight Mechanics (Estimation Theory …, 1991 | 1 | 1991 |
| COBE attitude refinement EL Wright, VK Kumar, I Freedman, A Rae, S Basappa, R Venkataraman, ... AIP Conference Proceedings 222 (1), 179-182, 1991 | 1 | 1991 |
Jyothy John, M. Pharm, Ph. D., R. Ph.Pharmacologist, USFDAVerified email at fda.hhs.gov
